Health policy is a historical product in the process of development, including the political and economic factors of the state as well as the social and cultural elements of the country. Bioethics began to debate the ethical questions that arise in the overall process of life's birth and death, and ...
Health policy is a historical product in the process of development, including the political and economic factors of the state as well as the social and cultural elements of the country. Bioethics began to debate the ethical questions that arise in the overall process of life's birth and death, and gradually evolved by presenting ethical directions for various social phenomena. Especially, according to the moral awakening of 'scientific medicine' which caused in some human problems in the rapidized scientific society from the late 19th century to the early 20th century, as a result of distress including the concept of various social relations, it is possible to say that it has reached the bioethics. Although health policy and bioethics are different in terms of starting and concept, they can be found in common with social, cultural, and political diversity in the times. In 2004, 'Bioethics Law' was enacted through the issue of research ethics in the life sciences. Therefore, in order to examine ethical aspects of current health policy direction and major issues, it can be divided into before and after enactment of 'Bioethics Law' in 2004. The authors would like to examine how the evolution of the ethical viewpoint on the health policy has changed in line with the enactment of the 'Bioethics Law' and how it is trying to solve it from an ethical point of view. Through the various events that took place in the 1990s and the 2000s, various discussions on bioethics were conducted in Korea. Prior to the enactment of the 'Bioethics Law,' ethical judgments of professions, distribution of healthcare resources, if the discussion focused on the ethical judgment of abortion, and the various events that appeared in the early 2000s became the beginning to inform that the ethical debate about the life, death, and dignity of human beings began in earnest in Korea with the enactment of the 'Bioethics Law.' Since then, 'Hospice and Palliative care Law' which was enacted in 2017, is based on the fact that the health policy of our country focuses on the treatment of the past diseases, health promotion, and delivery of health care services. It was an opportunity to let them know that even the quality problems were included. Therefore, considering the various circumstances, the ethical issue facing Korea's health care system in the future is the change of the demographic structure due to aging and what is to be considered as the beginning and the process of life in the overall process of life. It is the worry about how to die and when it sees as death. This has far exceeded the paradigm of traditional health care policies such as disease prevention and management and health promotion, and calls for innovative policy response at the national level that reflects the new paradigm, which in many cases creates a predictable ethical environment. And health policy should be shifted in the direction of future ethical review considering sustainability in the development process of future health care rather than coercive management.
Health policy is a historical product in the process of development, including the political and economic factors of the state as well as the social and cultural elements of the country. Bioethics began to debate the ethical questions that arise in the overall process of life's birth and death, and gradually evolved by presenting ethical directions for various social phenomena. Especially, according to the moral awakening of 'scientific medicine' which caused in some human problems in the rapidized scientific society from the late 19th century to the early 20th century, as a result of distress including the concept of various social relations, it is possible to say that it has reached the bioethics. Although health policy and bioethics are different in terms of starting and concept, they can be found in common with social, cultural, and political diversity in the times. In 2004, 'Bioethics Law' was enacted through the issue of research ethics in the life sciences. Therefore, in order to examine ethical aspects of current health policy direction and major issues, it can be divided into before and after enactment of 'Bioethics Law' in 2004. The authors would like to examine how the evolution of the ethical viewpoint on the health policy has changed in line with the enactment of the 'Bioethics Law' and how it is trying to solve it from an ethical point of view. Through the various events that took place in the 1990s and the 2000s, various discussions on bioethics were conducted in Korea. Prior to the enactment of the 'Bioethics Law,' ethical judgments of professions, distribution of healthcare resources, if the discussion focused on the ethical judgment of abortion, and the various events that appeared in the early 2000s became the beginning to inform that the ethical debate about the life, death, and dignity of human beings began in earnest in Korea with the enactment of the 'Bioethics Law.' Since then, 'Hospice and Palliative care Law' which was enacted in 2017, is based on the fact that the health policy of our country focuses on the treatment of the past diseases, health promotion, and delivery of health care services. It was an opportunity to let them know that even the quality problems were included. Therefore, considering the various circumstances, the ethical issue facing Korea's health care system in the future is the change of the demographic structure due to aging and what is to be considered as the beginning and the process of life in the overall process of life. It is the worry about how to die and when it sees as death. This has far exceeded the paradigm of traditional health care policies such as disease prevention and management and health promotion, and calls for innovative policy response at the national level that reflects the new paradigm, which in many cases creates a predictable ethical environment. And health policy should be shifted in the direction of future ethical review considering sustainability in the development process of future health care rather than coercive management.
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
문제 정의
따라서 본 연구는 ‘생명윤리법’ 제정시기와 맞물려 보건의료정책에 대한 윤리적 관점의 논의 전개가 어떻게 변화하였으며, 이를 윤리적 관점에서 어떻게 해결해 나아가기 위해 노력하고 있는가를 살펴보고자 한다.
제안 방법
이에 따라 앞서 언급한 기존의 ‘생명윤리법’이 가지고 있던 다양한 연구에 대한 활성화를 위한 정책적 방향과는 달리 줄기세포를 포함한 유전체 연구의 규제와 문제 발생 시 해당 연구참여자에 대한 기타 다른 연구의 참여제한 등을 골자로 한 규제적인 정책방향을 변화하였다.
질의응답
핵심어
질문
논문에서 추출한 답변
보건의료정책의 하위 요소는 무엇인가?
보건의료정책은 보건의료서비스의 공급구조와 보건의료자원, 서비스 제공에 따른 지불제도, 서비스공급자와 소비자(환자 등)의 행태 등 다양한 요소를 포함하고 있으며 궁극적으로 한 국가 내에서 제공하는 보건의료서비스의 지역적 차이를 극복하기 위한 보건 의료자원의 배치 및 분배, 효율적 운영을 목표로 발전해왔다고 볼 수 있다. 그에 따라 보건의료정책은 시행하는 국가의 정치, 경제적 요인뿐 아니라 그 나라의 사회ᆞ문화적 요소를 포함한 발전과정 속의 역사적 산물이라고 볼 수도 있다.
보건의료정책의 궁극적 목표는 무엇인가?
보건의료정책은 보건의료서비스의 공급구조와 보건의료자원, 서비스 제공에 따른 지불제도, 서비스공급자와 소비자(환자 등)의 행태 등 다양한 요소를 포함하고 있으며 궁극적으로 한 국가 내에서 제공하는 보건의료서비스의 지역적 차이를 극복하기 위한 보건 의료자원의 배치 및 분배, 효율적 운영을 목표로 발전해왔다고 볼 수 있다. 그에 따라 보건의료정책은 시행하는 국가의 정치, 경제적 요인뿐 아니라 그 나라의 사회ᆞ문화적 요소를 포함한 발전과정 속의 역사적 산물이라고 볼 수도 있다.
보건의료정책과 생명윤리가 충돌하는 사례는 무엇인가?
특히 다양한 관점의 윤리적 문제들은 보건의료정책 내 의료의 각 부문과 요소들이 발전하는 과정 속에서 기술과 정책의 발달과 국민의 의식수준이 증가함에 따라 처음 제기되기 시작하였다. 예를 들어 시험관 아기시술을 통한 보조생식술에 대한 윤리적 문제와 인공임신중절을 통한 남아와 여아의 성감별에 따른 윤리의 문제가 제기되기도 하였으며, 장기이식기술의 발달을 통하여 뇌사와 장기이식 관련 윤리문제가 대두되었다. 또한 의료기술의 발달에 따른 무의미한 연명의료의 중단과 존엄사의 문제, 배아복제의 윤리문제 등이 출현하였다[3].
참고문헌 (13)
Benatar D. Bioethics and health and human rights: a critical view. J Med Ethics 2006;32(1):17-20. DOI: https://doi.org/10.1136/jme.2005.011775.
Fotion N. Why medical ethics? Fernbank Q 1977;3(3).
Kim OJ, Park YH, Hyun BG. Development of the codes and guidelines of medical ethics in Korea. J Korean Med Assoc 2017;60(1):8-17. DOI: https://doi.org/10.5124/jkma.2017.60.1.8.
Kwon I. A critical review of the current medical ethics education in Korea. Korean J Med Ethics Educ 2006;9(1):60-72.
Roh K. Policy issues and direction for social service provision. Sejong: Korea Development Institute; 2011.
Sohn M, Yu HJ. The ethical review on the basic law for health and medical feld. Korean J Med Law 2002;10(1):85-95.
Lee S. The present and future of organ transplantation act of Korea. Seoul: Korean Institute of Criminology; 2000.
Cheong YS. An Internet-based discussion on Korean medico-ethical cases. Korean J Med Ethics Educ 1999;2(1):177-188.
Koo YM, Hwang SI. Some ethical problems concerning the cloning research and its application. Korean J Med Ethics Educ 2000;3(2):199-209.
Hong SY. A critical review on the 'Bioethics & Biosafety Law'. J Korean Bioeth Assoc 2004;5(1):13-23.
Kim EA. An examination of the current legislation and policies concerning the use of ART in Korea. J Korean Med Ethics 2010;13(3):205-227.
Beauchamp TL, Childress JF. Principles of biomedical ethics. New York (NY): Oxford University Press; 1979.
Kim B, Kim M. Using a health care proxy to overcome limitations of the act on decisions on life-sustaining treatment. J Korean Med Ethics 2018; 21(2):95-113.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.